667208 |
FRONTIERS IN GENETICS |
Identifying RNA N6-Methyladenine Sites in Three Species Based on a Markov Model |
2021-03-19 |
10.3389/fgene.2021.650803 |
Pian Cong, Yang Zhixin, Yang Yuqian, Zhang Liangyun, Chen Yuanyuan |
667207 |
FRONTIERS IN GENETICS |
Advances in the Identification of Circular RNAs and Research Into circRNAs in Human Diseases |
2021-03-19 |
10.3389/fgene.2021.665233 |
Jiao Shihu, Wu Song, Huang Shan, Liu Mingyang, Gao Bo |
667206 |
FRONTIERS IN GENETICS |
Immune Cell Infiltration-Based Characterization of Triple-Negative Breast Cancer Predicts Prognosis and Chemotherapy Response Markers |
2021-03-19 |
10.3389/fgene.2021.616469 |
Lv Yufei, Lv Dongxu, Lv Xiaohong, Xing Ping, Zhang Jianguo, Zhang Yafang |
667205 |
FRONTIERS IN GENETICS |
Genomic Variations in SARS-CoV-2 Genomes From Gujarat: Underlying Role of Variants in Disease Epidemiology |
2021-03-19 |
10.3389/fgene.2021.586569 |
Joshi Madhvi, Puvar Apurvasinh, Kumar Dinesh, Ansari Afzal, Pandya Maharshi, Raval Janvi, Patel Zarna, Trivedi Pinal, Gandhi Monika, Pandya Labdhi, Patel Komal, Savaliya Nitin, Bagatharia Snehal, Kumar Sachin, Joshi Chaitanya |
667204 |
FRONTIERS IN GENETICS |
The Effect of Sodium Glucose Cotransporter 2 Inhibitors From a Human Genetic Perspective |
2021-03-19 |
10.3389/fgene.2021.658012 |
Liu Xing-zi, Zhang Hong |
667203 |
FRONTIERS IN GENETICS |
Functional Interrogation of Enhancer Connectome Prioritizes Candidate Target Genes at Ovarian Cancer Susceptibility Loci |
2021-03-19 |
10.3389/fgene.2021.646179 |
Wang Wei, Song Fengju, Feng Xiangling, Chu Xinlei, Dai Hongji, Tian Jing, Fang Xuan, Song Fangfang, Liu Ben, Li Lian, Li Xiangchun, Zhao Yanrui, Zheng Hong, Chen Kexin |
667202 |
FRONTIERS IN ONCOLOGY |
Efficacy of Anti-PD-1/PD-L1 Monotherapy or Combinational Therapy in Patients Aged 75 Years or Older: A Study-Level Meta-Analysis |
2021-03-19 |
10.3389/fonc.2021.538174 |
Nie Run-Cong, Chen Guo-Ming, Wang Yun, Zhou Jie, Duan Jin-Ling, Zhou Zhi-Wei, Yuan Shu-Qiang |
667201 |
FRONTIERS IN ONCOLOGY |
FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer |
2021-03-19 |
10.3389/fonc.2021.603660 |
Guo Zixin, Yan Xin, Song Congkuan, Wang Qingwen, Wang Yujin, Liu Xiao-Ping, Huang Jingyu, Li Sheng, Hu Weidong |
667200 |
FRONTIERS IN ONCOLOGY |
Overexpressed Tumor Suppressor Exosomal miR-15a-5p in Cancer Cells Inhibits PD1 Expression in CD8+T Cells and Suppresses the Hepatocellular Carcinoma Progression |
2021-03-19 |
10.3389/fonc.2021.622263 |
Zhang Hong-Yu, Liang Hong-Xia, Wu Shu-Huan, Jiang He-Qing, Wang Qin, Yu Zu-Jiang |
667199 |
FRONTIERS IN ONCOLOGY |
Cyclovirobuxine D Induces Apoptosis and Mitochondrial Damage in Glioblastoma Cells Through ROS-Mediated Mitochondrial Translocation of Cofilin |
2021-03-19 |
10.3389/fonc.2021.656184 |
Zhang Lin, Fu Ruoqiu, Duan Dongyu, Li Ziwei, Li Bin, Ming Yue, Li Li, Ni Rui, Chen Jianhong |